Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial

BACKGROUND: Chronic lymphocytic leukaemia (CLL) is the most common adult leukaemia. Combination immunochemotherapy such as fludarabine, cyclophosphamide and rituximab is the standard first line therapy in fit patients, but there is limited evidence regarding the optimal treatment of patients after r...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Dena R., Munir, Talha, Hockaday, Anna, Rawstron, Andy C., Collett, Laura, Oughton, Jamie B., Allsup, David, Bloor, Adrian, Phillips, David, Hillmen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028943/
https://www.ncbi.nlm.nih.gov/pubmed/27645620
http://dx.doi.org/10.1186/s13063-016-1581-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028943/
https://www.ncbi.nlm.nih.gov/pubmed/27645620
http://dx.doi.org/10.1186/s13063-016-1581-0

Ejemplares similares